Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 82,709 | 49,944 | 16,555 | -61,286 | -107,083 |
| Depreciation Amortization | 4,182 | 4,359 | 3,742 | -1,981 | -1,839 |
| Accounts receivable | 58 | -5,431 | 3,566 | -36,072 | -30,607 |
| Accounts payable and accrued liabilities | 1,538 | 2,339 | 1,789 | 4,797 | -436 |
| Other Working Capital | -26,152 | -30,646 | -5,968 | 18,133 | -3,578 |
| Other Operating Activity | 55,003 | 33,527 | 9,395 | 93,111 | 74,856 |
| Operating Cash Flow | $117,338 | $54,092 | $29,079 | $16,702 | $-68,687 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -369,333 | -217,846 | -80,154 | -357,732 | 12,253 |
| PPE Investments | -70 | N/A | N/A | -50 | -50 |
| Purchase Of Investment | N/A | N/A | 66,115 | N/A | -265,878 |
| Sale Of Investment | 216,715 | 147,615 | N/A | 429,780 | 326,020 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -40,000 |
| Other Investing Activity | 0 | 0 | 0 | -40,000 | -40,000 |
| Investing Cash Flow | $-152,688 | $-70,231 | $-14,039 | $31,998 | $32,345 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,876 | 4,608 | 1,043 | 25,129 | 19,695 |
| Financing Cash Flow | $4,876 | $4,608 | $1,043 | $25,129 | $19,695 |
| Exchange Rate Effect | -34 | 8 | 5 | -18 | -6 |
| Beginning Cash Position | 194,427 | 194,427 | 194,427 | 120,616 | 120,616 |
| End Cash Position | 163,919 | 182,904 | 210,515 | 194,427 | 103,963 |
| Net Cash Flow | $-30,508 | $-11,523 | $16,088 | $73,811 | $-16,653 |
| Free Cash Flow | |||||
| Operating Cash Flow | 117,338 | 54,092 | 29,079 | 16,702 | -68,687 |
| Capital Expenditure | -70 | N/A | N/A | -50 | -50 |
| Free Cash Flow | 117,268 | 54,092 | 29,079 | 16,652 | -68,737 |